Literature DB >> 7496771

Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth.

P Giunti1, M G Sweeney, A E Harding.   

Abstract

Affected members of 63 families with a variety of autosomal dominant late onset cerebellar ataxias (ADCA), and 29 patients with similar phenotypes but no affected relatives, were investigated for the trinucleotide (CAG) repeat expansion described in Japanese families with Machado-Joseph disease (MJD). This disorder had previously been shown to map to the region of chromosome 14 which also contains a locus causing ADCA in French families, spinocerebellar ataxia 3 (SCA3). The MJD/SCA3 mutation was identified in nine families with ADCA type I, and a further family in which affected members had parkinsonism, peripheral neuropathy, dystonia, and spasticity, but little evidence of cerebellar disease. Only one of the 10 families was British (the Drew family of Walworth); the others originated from India, Jamaica, Ghana, Brazil and France. There was no single clinical feature which distinguished patients with the MJD/SCA3 mutation from those with the CAG expansion on chromosome 6 (SCA1) or ADCA type I families with no known mutation. The CAG repeat length ranged from 13-41 copies on normal chromosomes and 62-80 copies on affected chromosomes. There was a significant inverse correlation between age of onset of symptoms and repeat length, but no significant effect of parental sex on repeat length or age of onset in offspring. DNA analysis for the MJD/SCA3 mutation is useful for diagnosis in patients with familial ataxic or extrapyramidal syndromes, and will aid genetic counselling in these disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496771     DOI: 10.1093/brain/118.5.1077

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  11 in total

Review 1.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

Review 2.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 3.  The inherited ataxias and the new genetics.

Authors:  S R Hammans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

4.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

5.  Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3.

Authors:  Mercedes Prudencio; Hector Garcia-Moreno; Karen R Jansen-West; Rana Hanna Al-Shaikh; Tania F Gendron; Michael G Heckman; Matthew R Spiegel; Yari Carlomagno; Lillian M Daughrity; Yuping Song; Judith A Dunmore; Natalie Byron; Björn Oskarsson; Katharine A Nicholson; Nathan P Staff; Sorina Gorcenco; Andreas Puschmann; João Lemos; Cristina Januário; Mark S LeDoux; Joseph H Friedman; James Polke; Robin Labrum; Vikram Shakkottai; Hayley S McLoughlin; Henry L Paulson; Takuya Konno; Osamu Onodera; Takeshi Ikeuchi; Mari Tada; Akiyoshi Kakita; John D Fryer; Christin Karremo; Inês Gomes; John N Caviness; Mark R Pittelkow; Jan Aasly; Ronald F Pfeiffer; Venka Veerappan; Eric R Eggenberger; William D Freeman; Josephine F Huang; Ryan J Uitti; Klaas J Wierenga; Iris V Marin Collazo; Philip W Tipton; Jay A van Gerpen; Marka van Blitterswijk; Guojun Bu; Zbigniew K Wszolek; Paola Giunti; Leonard Petrucelli
Journal:  Sci Transl Med       Date:  2020-10-21       Impact factor: 17.956

Review 6.  The Geographic Diversity of Spinocerebellar Ataxias (SCAs) in the Americas: A Systematic Review.

Authors:  Hélio A G Teive; Alex T Meira; Carlos Henrique F Camargo; Renato P Munhoz
Journal:  Mov Disord Clin Pract       Date:  2019-08-16

7.  Mouse ataxin-3 functional knock-out model.

Authors:  Pawel M Switonski; Agnieszka Fiszer; Katarzyna Kazmierska; Maciej Kurpisz; Wlodzimierz J Krzyzosiak; Maciej Figiel
Journal:  Neuromolecular Med       Date:  2010-10-14       Impact factor: 3.843

8.  Large normal-range TBP and ATXN7 CAG repeat lengths are associated with increased lifetime risk of depression.

Authors:  S L Gardiner; M J van Belzen; M W Boogaard; W M C van Roon-Mom; M P Rozing; A M van Hemert; J H Smit; A T F Beekman; G van Grootheest; R A Schoevers; R C Oude Voshaar; H C Comijs; B W J H Penninx; R C van der Mast; R A C Roos; N A Aziz
Journal:  Transl Psychiatry       Date:  2017-06-06       Impact factor: 6.222

9.  Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation.

Authors:  Nester Mitchell; Gaynel A LaTouche; Beverly Nelson; Karla P Figueroa; Ruth H Walker; Andrew K Sobering
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-09-13

10.  Clinical analysis of adult-onset spinocerebellar ataxias in Thailand.

Authors:  Pairoj Boonkongchuen; Sunsanee Pongpakdee; Panitha Jindahra; Chutima Papsing; Powpong Peerapatmongkol; Suppachok Wetchaphanphesat; Supachai Paiboonpol; Charungthai Dejthevaporn; Surat Tanprawate; Angkana Nudsasarn; Chanchai Jariengprasert; Dittapol Muntham; Atiporn Ingsathit; Teeratorn Pulkes
Journal:  BMC Neurol       Date:  2014-04-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.